Water Street announces agreement to invest in Solvias

Water Street Healthcare Partners, a strategic investor focused exclusively on the health care industry, announced on February 25, 2020, that it has signed a definitive agreement to invest in Solvias AG. Headquartered in the biotech hub of Basel, Switzerland, Solvias is one of the largest independent pharmaceutical laboratory platforms in Europe. Water Street, which has years of experience in the pharmaceutical services sector, will partner with the company's management team to build Solvias into a premier global pharmaceutical laboratory services business. The transaction is expected to close in the first half of 2020.
Lenz & Staehelin acts as Swiss legal advisor to Water Street in this transaction. The team is led by Guy Vermeil and Roman Graf (both Corporate and M&A) and involved partners Floran Ponce (Tax) and David Ledermann (Financing), counsel Sara Rousselle-Ruffieux (Employment), associates Ralph Kaufmann and Loïc Machado (both Corporate and M&A), Clément Bouvier (Financing), Sevan Antreasyan (Intellectual Property), as well as Emilia Rebetez and Maximilien De Ridder (both Tax), among others.
Kirkland & Ellis LLP acts as international legal advisor to Water Street.

Published: 6 March 2020